je.st
news
Biotech companies lobby intensively to restrict generics
2013-01-30 16:59:04| Biotech - Topix.net
In statehouses around the country, some of the nation's biggest biotechnology companies are lobbying intensively to limit generic competition to their blockbuster drugs, potentially cutting into the billions of dollars in savings on drug costs contemplated in the federal health care overhaul law.
Tags: companies
lobby
restrict
biotech
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|